{
    "SPADE_UN_13915": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13915",
            "Peptide Name": "NL6-2",
            "Source": "Synthetic construct(derived from HIV-1 integrase)",
            "Family": "Retroviridae",
            "Gene": "Not found",
            "Sequence": "TAYFLLILAGRW",
            "Sequence Length": 12,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.16854053]HIV-1:Inhibition of 3′-processing catalyzed by integrase(IC50=4.1±0.7 µM);inhibition of strand transfer catalyzed by integrase(IC50=3.0±1.0  µM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "Integrase",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C71H106N16O15",
            "Mass": 1423.7,
            "PI": 8.41,
            "Net Charge": 1,
            "Hydrophobicity": 1.21,
            "Half Life": "Mammalian:7.2 hourYeast:>20 hourE.coli:>10 hour",
            "Mechanism of action": "HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis",
            "Literature": [
                {
                    "Title": "Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase insight into the binding mode of the enzyme.",
                    "Pubmed ID": "16854053",
                    "Reference": "J Med Chem. 2006 Jul 27;49(15)4477-86.",
                    "Author": "Li HY, Zawahir Z, Song LD, Long YQ, Neamati N.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16854053"
                }
            ],
            "Frequent Amino Acids": "LAF",
            "Absent Amino Acids": "CDEHKMNOPQSUV",
            "Basic Residues": 1,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 5,
            "Positive Residues": 1,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13921",
                    "Similarity": 1.0,
                    "Sequence": "TAYFLL"
                },
                {
                    "SPADE_ID": "SPADE_UN_13884",
                    "Similarity": 0.9166666666666666,
                    "Sequence": "TAYFLLKLAGRW"
                },
                {
                    "SPADE_ID": "SPADE_UN_13900",
                    "Similarity": 0.9166666666666666,
                    "Sequence": "TAYFLLALAGRW"
                }
            ]
        }
    }
}